Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BGM Group Ltd. (BGM : NSDQ)

• Company Description    BGM Group Ltd. is a company dedicated to the fields of biopharmaceuticals, bio-extraction and medical health. Its current product range includes oxytetracycline APIs, licorice preparations and crude heparin sodium. BGM Group Ltd., formerly known as Qilian International Holding Group Ltd., is headquartered in Chengdu, China. Number of Employees: 323

• Price / Volume Information    Yesterday's Closing Price: $9.66 Daily Weekly Monthly 20 Day Moving Average: 74,807 shares Shares Outstanding: 97.22 (millions) Market Capitalization: $939.17 (millions) Beta: 1.29 52 Week High: $17.17 52 Week Low: $4.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.12% -40.43% 12 Week -12.22% -26.16% Year To Date 14.32% 7.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL NO. 152 HONGLIANG EAST 1ST STREET NO. 1703 TIANFU NEW DISTRICT - CHENGDU,F4 610200 CHN ph: 86-028-6477-5180 fax: - tina.xiao@ascent-ir.com http://www.bgm.ltd

• General Corporate Information    Officers Chen Xin - Chief Executive Officer Zhanchang Xin - Chairman of the Board of Directors Yaxuan Zhai - Chief Financial Officer Waihua Xu - Independent Director Ming Jing - Independent Director Peer Information BGM Group Ltd. (CORR.) BGM Group Ltd. (RSPI) BGM Group Ltd. (CGXP) BGM Group Ltd. (BGEN) BGM Group Ltd. (GTBP) BGM Group Ltd. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G7307E123 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 97.22 Most Recent Split Date: 6.00 (0.20:1) Beta: 1.29 Market Capitalization: $939.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.32 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©